In vitro studies performed on NSCLC cell lines such as A549 and H460 showed that both RNAi-mediated silencing of HSPA1 expression or chemical inhibition of HSPA function led to reduced cell proliferation35,36. This evidence concerns the gene HSPA1B and non-small cell lung carcinoma.